If there is any information that you would like included on this page please contact Alexandra Fullem (alexfullem@gmail.com).  The website is updated approximately twice a month.

PDP Press Releases/ statements

IAVI 

• 28 Oct: IAVI awarded $36 million from BARDA for Bundibugyo virus vaccine development

IVCC

 • 1 Oct: Sustaining the UK’s malaria science leadership at Labour Party Conference

• 7 Oct: Malaria Science Index highlights the importance of investment and partnerships in malaria innovation

TB Alliance

• 5 Oct: TB Alliance Announces Three Leadership Appointments

• 7 Oct: TB Alliance Launches Creator Collective to Highlight TB In the Global Conversation

GARDP 

• 22 Jul: Last-resort antibiotics remain out of reach in Latin America and the Caribbean, review warns

Population Council

 • 4 Feb: Contraline and Population Council Execute Global Exclusive License Agreement for NES/T Male Contraception Gel

PATH

• 29 Oct: Ares and PATH bet on better health

• 29 Oct: PATH and iBody partner to develop a diagnostic for Nipah virus and Hendra virus 

MMV

• 2 Nov: Africa's first-ever Phase 1 trial of a long-acting injectable for malaria prevention launches in Rwanda

• 20 Oct: MMV recognized as a “Very High Performer” in the Global Health 50/50 Gender & Health Index for fifth consecutive year

• 23 Oct: African healthcare providers favour a long-acting injectable to simplify malaria prevention

DNDi

• 2 Nov: Project to develop dengue treatment pre-selected by the Global Coalition for Local and Regional Production, Innovation, and Equitable Access

• 9 Oct: DNDi 2026 Projects of the Year recognize teams and partners for their work to advance an open-science antiviral for future coronavirus pandemics and a single-dose treatment for sleeping sickness

• 27 Oct: Kenya becomes first African country to join the Dengue Alliance. DNDi

• 29 Oct: DNDi welcomes GHIT Fund’s support for innovative approaches to improve success in Chagas disease drug discovery with Nagasaki University, the University of Dundee, and Eisai . DNDi

FIND

•  8 Oct: FIND Board appoints Dr Jutta Reinhard-Rupp as FIND’s Chief Executive Officer

IVI

• 3 Sep: IVI and Karolinska Institutet sign Memorandum of Understanding to strengthen existing cooperation in vaccine research and education

EVI

• 28 Oct: European Vaccine Initiative and Novo Nordisk Foundation launch new network to advance mucosal immunity research for airway vaccines: AVANT-guard

MDGH

• 29 Sep: First participant enrolled in a Phase 3 clinical trial of moxidectin for lymphatic filariasis and other neglected tropical diseases in Fiji

PDP Funder News/Announcements

• 2 Nov: U.S. FDA approves first generic injectable lenacapavir for HIV prevention. Unitaid

• 29 Oct: Total Investment of Approx. USD 6.8 Million in Product Development for Malaria, NTDs and Other Emerging & Re-emerging Infectious Diseases such as Ebola Disease. GHIT

Funder Announcement Archives

     •     2014 PDP Funder Announcements

     •     2013 PDP Funder Announcements

New PDP Publications

•  11 Oct: Research, innovation and product development in the evolving global health ecosystem: an essential global public good. Numerous PDPs

•  12 Oct: What is the future of product development?. Numerous PDPs

•  19 Oct: Strengthening WHO’s role in public health innovation: a PDP perspective. Numerous PDPs

Other Reports/ Publications

• 21 Oct: Pipeline Report » 2026 Tuberculosis Vaccines. TAG

Related Press Releases/ Announcements/Articles

• 1 Oct: Commentary: Global health research makes America richer and healthier. University of Michigan Health

• 1 Oct: Sluggish donor response to CEPI’s pandemic prevention ask. Development Today

• 1 Oct: Can Africa make 60% of its vaccines by 2040? That’s a tall order, as the travails of South African companies show. Science

• 1 Oct: Symptom-agnostic endpoints in tuberculosis vaccine efficacy trials. The Lancet

• 1 Oct: Early lessons from lenacapavir PrEP roll-out in Zimbabwe. The Lancet HIV

• 2 Nov: First ever trial of long-acting injection against malaria to launch in Africa. The Telegraph

• 2 Nov: Malaria control: Who decides Africa’s gene-drive future?. SciDevNet

• 2 Oct: Addressing mosquito-borne disease trends as climate change bites. MedicalXpress

• 3 Nov: Global Fund Board Approves New Financing Mechanism to Accelerate Progress Against Malaria and Marks Leadership Transition. The Global Fund

• 5 Oct: Opinion: Fostering affordable and equitable biomedical innovation. Business Line

• 6 Oct: Three Questions the Bundibugyo Ebola Outbreak Asks of CEPI’s 100 Days Mission. Geneva Health Files

• 6 Oct: Uganda launches Phase I clinical study of Bundibugyo virus disease vaccine. LSHTM

• 7 Oct: H.I.V. Research Networks Face Uncertain Future Amid Funding Delays. The New York Times

• 8 Oct: How a new long-acting HIV drug combo tackles resistance. MedicalXpress

• 8 Oct: Why is dengue spreading while malaria has declined?. News Medical

• 8 Oct: NIH revives network to study emerging diseases—but its new restrictions baffle scientists. Science

• 9 Oct: Germany Hosts the World Health Summit, But Has No Plan for the World’s Health. Health Policy Watch

• 9 Oct: Is the global health architecture reform progressing?. Global Public Health Insights

• 10 Oct: Beyond the Breakthrough: Why New HIV Prevention Needs a Delivery Revolution for Girls. SHRM

• 10 Oct: 50 years of Ebola research and response. The Lancet

• 12 Oct: Final preparations underway for pivotal Phase 2/3 Bundibugyo vaccine trial. CEPI

• 12 Oct: Why scientific breakthroughs won't end HIV if communities are left behind. The Advocate

• 12 Oct: Exclusive: Global Fund eyes new funding mechanism for malaria. Devex

• 13 Oct: When PrEP Options Are Equally Attractive, Should Their Carbon Footprint Tip the Balance?. The Body Pro

• 13 Oct: With Only Three ‘No’ Votes, UN Adopts Political Declaration on Pandemic Preparedness. Health Policy Watch

• 13 Oct: Mosquito-based malaria control through genetic, microbial and immunological innovations. Nature

• 14 Oct: Innovative roadmaps for sustainable antimicrobial resistance interventions. Science

• 14 Oct: Mosquito saliva study opens new doors for blocking Zika, dengue, and West Nile infections. News Medical

• 14 Oct: Ebola vaccine triggers cross reactive T cells against Bundibugyo ebolavirus. News Medical

• 15 Oct: HIV finds escape routes from a preventive antibody—but newer antibodies may close them. MedicalXpress

• 15 Oct: Good gut bacteria vs bad: what we learnt about antibiotic resistance from a community in Nairobi. The Conversation

• 15 Oct: Medicines for Malaria Venture and Deepmirror dd4gh. Time Magazine

• 15 Oct: Public and private funders inject €159 million in global health research. Science Business

• 15 Oct: Africa’s Pooled Procurement Mechanism Seeks to Lower Medical Product Costs. Africa CDC

• 15 Oct: Cross-neutralisation of authentic Ebola virus and Bundibugyo virus following natural infection or Ervebo vaccination. The Lancet

• 16 Oct: Continuity Biosciences Secures $9.6M Gates Foundation Grant to Advance Multi-Year HIV Prevention Implant. BioPharma

• 16 Oct: Vaccine target of 100 days isn’t fast enough, says CEPI chair—while expert warns of failure to provide basic care in DRC Ebola outbreak. BMJ

• 16 Oct: CEPI and World Bank Group partner to strengthen sustainable vaccine manufacturing in ASEAN. CEPI

• 16 Oct: World Health $ummit: The Necessary Evil of Capitalist Global Health?. IHP

• 16 Oct: First participants vaccinated with Oxford's CEPI-backed Lassa shot in Ghana. CEPI

• 16 Oct: Resetting global health: sovereignty must strengthen rights, not replace them. BMJ

• 16 Oct: Funding cuts threaten to stall global health innovations. Devex

• 18 Oct: Ebola vaccine trials 'reason for hope' in DR Congo and beyond. RFI

• 19 Oct: Global Health Research in the America First Era. Think Global Health

• 19 Oct: AI firm Anthropic to commit 5% of shares to fund for ‘public good’. The Guardian

• 19 Oct: How WHO's pandemic hub plans to identify all new threats within 24 hours. Devex

• 20 Oct: Devex CheckUp: Is a consensus forming around the future of global health?. Devex

• 20 Oct: A.I. Fortunes Could Bring Critical Funds to Global Health. The Scramble Is On. The New York Times

• 20 Oct: As Ebola epidemic rages, Congo bets on high-stakes ‘hope’ vaccine trial. Science

• 20 Oct: New TB vaccines are coming. How are countries preparing for the rollout?. Gavi

• 20 Oct: Is tuberculosis eradication actually in sight?. Devex

• 21 Oct: African trial optimises dose of drug with potential to improve outcomes in children with severe malaria. Imperial College

• 21 Oct: Now What with Injectable LEN for PrEP? How to Translate Ambition into Accelerated Delivery and Impact. AVAC

• 21 Oct: Sevuparin in children with severe malaria: a phase I safety and dose-finding trial. Nature

• 21 Oct: Drug-resistant infections linked to $3.5 trillion in global economic losses in 2021. CIDRAP

• 22 Oct: Gavi and UNICEF secure lower malaria vaccine price, saving US$ 50 million for childhood immunisation programmes. Gavi

• 22 Oct: A five-year look into how a malaria vaccine changed Ghana. The World

• 22 Oct: African health manufacturers need reliable buyers, not just investment. Devex

• 22 Oct: Global health deserves better criticism. The Lancet Global Health

• 22 Oct: UNICEF and Gavi agree to cut Mosqivac malaria vaccine price by 40%. Reuters

• 23 Oct: First participant vaccinated in pivotal Phase 2/3 Bundibugyo vaccine trial in DRC. CEPI

• 23 Oct: How viruses hijack mosquito saliva to help them infect us. Gavi

• 23 Oct: Long-acting injected combo drug keeps HIV in check, real-world study finds. CIDRAP

• 23 Oct: Most Countries Give Thumps Up for UN Political Declaration on Pandemics, Give Currency to The Negotiations on the WHO Pathogen Access & Benefit Sharing Mechanism. Geneva Health Files

• 26 Oct: Global Diagnostics Coalition urges action as 47% lack access to timely diagnosis. DeviDiscourse

• 26 Oct: Strengthening Africa’s outbreak-ready evidence generation capabilities. CEPI

• 27 Oct: Devex Newswire: Big news on who's behind Anthropic's Public Benefit Fund. Devex

• 27 Oct: After a busy season of multilateral convenings on global health, from the United Nations General Assembly to the World Health Summit, GHTC is reflecting on our major takeaways from these fora amid major shifts in the broader global health architecture. GHTC

• 27 Oct: New EU-funded project to advance rapid diagnosis of childhood infections in Africa. Imperial

• 27 Oct: The New TB Vaccines Are Coming! How Can We Prepare for the Rollout?. Gavi

• 28 Oct: Research organization IAVI receives US funding for Ebola vaccine development. Reuters

• 28 Oct: WHO releases target regimen profiles for long-acting injectables for TB. WHO

• 28 Oct: Ebola vaccines must reach outbreak-affected communities and countries without delay. MSF

• 29 Oct: EMA and AMA’s Joint Ebola Vaccine Guidance Is a Regulatory Harmonization Blueprint Sponsors Can’t Afford to Miss. The Vanguard

• 29 Oct: Abuja Ministerial Meeting Offers Governments a Chance to Recommit to Fighting AMR. Health Policy Watch

• 29 Oct: The hard work of health sovereignty starts now. Devex

• 30 Oct: In Kilifi, Kenya, malaria is vanishing from the children’s wards. Gavi

• 30 Oct: EXCLUSIVE: Dismissing Geneva Mergers, Global Fund’s Dybul Wants to Focus on Country Capacity. Health Policy Watch

Upcoming Meetings/  Webinars

--------------------------